MED PAPER is selling at 20.10 as of the 1st of December 2024; that is 1.95% down since the beginning of the trading day. The stock's last reported lowest price was 20.02. MED PAPER has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for MED PAPER are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Although MED PAPER's alpha and beta are two of the key measurements used to evaluate MED PAPER's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MED PAPER stock to make a market-neutral strategy. Peer analysis of MED PAPER could also be used in its relative valuation, which is a method of valuing MED PAPER by comparing valuation metrics with similar companies.
When running MED PAPER's price analysis, check to measure MED PAPER's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MED PAPER is operating at the current time. Most of MED PAPER's value examination focuses on studying past and present price action to predict the probability of MED PAPER's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MED PAPER's price. Additionally, you may evaluate how the addition of MED PAPER to your portfolios can decrease your overall portfolio volatility.